{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:21:31Z","timestamp":1793157691935,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010608","name":"Universit\u00e0 degli Studi di Urbino Carlo Bo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008385","name":"Cystic Fibrosis Research Foundation","doi-asserted-by":"publisher","award":["FFC#07\/2023"],"award-info":[{"award-number":["FFC#07\/2023"]}],"id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biofilm"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioflm.2026.100370","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:14:34Z","timestamp":1780013674000},"page":"100370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Evidence of cefiderocol-persistence in Pseudomonas aeruginosa in vitro biofilms and in a murine infection model"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5035-5879","authenticated-orcid":false,"given":"Gianmarco","family":"Mangiaterra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Lucidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Piccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gugliandolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"De Fino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rossano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Vignaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Visca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bragonzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Citterio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioflm.2026.100370_bib1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/35023079","article-title":"Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen","volume":"406","author":"Stover","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bioflm.2026.100370_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104532","article-title":"Phylogroup-specific variation shapes the clustering of antimicrobial resistance genes and defence systems across regions of genome plasticity in Pseudomonas aeruginosa","volume":"90","author":"Botelho","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bioflm.2026.100370_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/science.adi0908","article-title":"Evolution and host-specific adaptation of Pseudomonas aeruginosa","volume":"385","author":"Weimann","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.bioflm.2026.100370_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jinf.2016.11.008","article-title":"Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance","volume":"74","author":"Fern\u00e1ndez-Barat","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.bioflm.2026.100370_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcf.2022.08.007","article-title":"Impact of antibiotic eradication therapy of Pseudomonas aeruginosa on long term lung function in cystic fibrosis","volume":"22","author":"Casaredi","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.bioflm.2026.100370_bib6","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bioflm.2026.100370_bib7","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1038\/s41467-024-52595-w","article-title":"Targeting Pseudomonas aeruginosa biofilm with an evolutionary trained bacteriophage cocktail exploiting phage resistance trade-offs","volume":"15","author":"Kunisch","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.bioflm.2026.100370_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41467-023-36244-2","article-title":"Future therapies for cystic fibrosis","volume":"14","author":"Allen","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.bioflm.2026.100370_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41522-022-00346-4","article-title":"Biofilm antimicrobial susceptibility through an experimental evolutionary lens","volume":"8","author":"Coenye","year":"2022","journal-title":"npj Biofilms Microbiomes"},{"key":"10.1016\/j.bioflm.2026.100370_bib10","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jcf.2019.04.009","article-title":"Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung","volume":"18","author":"Malhotra","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.bioflm.2026.100370_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41579-019-0196-3","article-title":"Definitions and guidelines for research on antibiotic persistence","volume":"17","author":"Balaban","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bioflm.2026.100370_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00249-18","article-title":"Relationship between the viable but nonculturable state and antibiotic persister cells","volume":"200","author":"Ayrapetyan","year":"2018","journal-title":"J Bacteriol"},{"key":"10.1016\/j.bioflm.2026.100370_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2024.02.013","article-title":"Role of viable but non culturable cells in patients with cystic fibrosis in the era of highly effective modulator therapy","author":"Cirilli","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.bioflm.2026.100370_bib14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1186\/s12879-018-3612-9","article-title":"Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study","volume":"18","author":"Mangiaterra","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bioflm.2026.100370_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcf.2013.09.002","article-title":"Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis","volume":"13","author":"Stanojevic","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.bioflm.2026.100370_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411618","article-title":"Involvement of acquired tobramycin resistance in the shift to the viable but non-culturable state in Pseudomonas aeruginosa","volume":"24","author":"Mangiaterra","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bioflm.2026.100370_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bioflm.2026.100370_bib18","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1128\/AAC.01405-16","article-title":"Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa","volume":"60","author":"Ito","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100370_bib19","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1007\/s10311-021-01242-7","article-title":"Iron-withdrawing anti-infectives for new host-directed therapies based on iron dependence, the Achilles' heel of antibiotic-resistant microbes","volume":"9","author":"Holbein","year":"2021","journal-title":"Environ Chem Lett"},{"key":"10.1016\/j.bioflm.2026.100370_bib20","doi-asserted-by":"crossref","first-page":"S538","DOI":"10.1093\/cid\/ciz826","article-title":"Cefiderocol: discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin","volume":"69","author":"Sato","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bioflm.2026.100370_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2022.11.014","article-title":"Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"29","author":"L\u00f3pez-Causap\u00e9","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bioflm.2026.100370_bib22","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jac\/dkae126","article-title":"In vitro activity of cefiderocol in Pseudomonas aeruginosa isolates from people with cystic fibrosis recovered during three multicentre studies in Spain","volume":"79","author":"Maruri-Aransolo","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2026.100370_bib23","article-title":"Cefiderocol activity against planktonic and biofilm forms of \u03b2-lactamase-producing Pseudomonas aeruginosa from people with cystic fibrosis","volume":"28","author":"Fabrizio","year":"2025","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.bioflm.2026.100370_bib24","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1093\/jac\/dkae346","article-title":"Differential frequency of persister cells in clinically derived isolates of Pseudomonas aeruginosa after exposure to cefiderocol and ceftolozane\/tazobactam","volume":"79","author":"Fouad","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2026.100370_bib25","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1073\/pnas.1222706110","article-title":"Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity","volume":"110","author":"Imperi","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bioflm.2026.100370_bib26","series-title":"Performance standards for antimicrobial susceptibility testing: twenty-seventh informational supplement M100-S27","year":"2020"},{"key":"10.1016\/j.bioflm.2026.100370_bib27","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/jac\/dkv496","article-title":"New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection","volume":"71","author":"Revest","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2026.100370_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02956-20","article-title":"Generation of genetic tools for gauging multiple-gene expression at the single-cell level","volume":"87","author":"Mellini","year":"2021","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.bioflm.2026.100370_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03690-23","article-title":"Expanding the microbiologist toolbox via new far-red-emitting dyes suitable for bacterial imaging","volume":"12","author":"Lucidi","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.bioflm.2026.100370_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0167-7012(02)00128-8","article-title":"Direct estimate of active bacteria: CTC use and limitations","volume":"52","author":"Cr\u00e9ach","year":"2003","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.bioflm.2026.100370_bib31","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1007\/s00253-016-7396-9","article-title":"Is biofilm removal properly assessed? Comparison of different quantification methods in a 96-well plate system","volume":"100","author":"Stiefel","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.bioflm.2026.100370_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101061","article-title":"Phage-mediated colistin resistance in Acinetobacter baumannii","volume":"73","author":"Lucidi","year":"2024","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.bioflm.2026.100370_bib33","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1083\/jcb.201602028","article-title":"Unique spectral signatures of the nucleic acid dye acridine orange can distinguish cell death by apoptosis and necroptosis","volume":"216","author":"Plemel","year":"2017","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bioflm.2026.100370_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00677-23","article-title":"Redundant essentiality of AsmA-like proteins in Pseudomonas aeruginosa","volume":"9","author":"Sposato","year":"2024","journal-title":"mSphere"},{"key":"10.1016\/j.bioflm.2026.100370_bib35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ijmm.2010.08.012","article-title":"Murine models of acute and chronic lung infection with cystic fibrosis pathogens","volume":"300","author":"Bragonzi","year":"2010","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.bioflm.2026.100370_bib36","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02456-2018","article-title":"Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa","volume":"55","author":"Cigana","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bioflm.2026.100370_bib37","article-title":"Long term chronic Pseudomonas aeruginosa airway infection in mice","volume":"85","author":"Facchini","year":"2014","journal-title":"J Vis Exp"},{"key":"10.1016\/j.bioflm.2026.100370_bib38","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/978-1-4939-0473-0_58","article-title":"Assessing Pseudomonas aeruginosa virulence and the host response using murine models of acute and chronic lung infection","volume":"1149","author":"Kukavica-Ibrulj","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bioflm.2026.100370_bib39","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1164\/rccm.200812-1943OC","article-title":"Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence","volume":"180","author":"Bragonzi","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bioflm.2026.100370_bib40","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.3390\/ijms22041628","article-title":"Contribution of drugs interfering with protein and cell wall synthesis to the persistence of Pseudomonas aeruginosa biofilms: an in vitro model","volume":"22","author":"Mangiaterra","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bioflm.2026.100370_bib41","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.tim.2023.04.009","article-title":"Viable but nonculturable (VBNC) state, an underestimated and controversial microbial survival strategy","volume":"31","author":"Liu","year":"2023","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.bioflm.2026.100370_bib42","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1093\/cid\/ciz830","article-title":"Treatment options for carbapenem-resistant gram-negative bacterial infections","volume":"69","author":"Doi","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bioflm.2026.100370_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jgar.2024.01.021","article-title":"Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa","volume":"37","author":"Ferretti","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.bioflm.2026.100370_bib44","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1128\/AAC.00757-16","article-title":"In vitro emergence of high persistence upon periodic aminoglycoside challenge in the ESKAPE pathogens","volume":"60","author":"Michiels","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100370_bib45","doi-asserted-by":"crossref","first-page":"e00700","DOI":"10.1128\/AAC.00700-17","article-title":"Efficacy of cefiderocol against carbapenem-resistant gram-negative Bacilli in immunocompetent-rat respiratory tract infection models recreating human plasma pharmacokinetics","volume":"61","author":"Matsumoto","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100370_bib46","article-title":"Impact of transferable betalactamases and intrinsic AmpC amino acid substitutions on the activity of cefiderocol against wildtype and iron uptake-deficient mutants of Pseudomonas aeruginosa","volume":"17","author":"Gonz\u00e1lez-Pinto","year":"2024","journal-title":"J Antimicrob Chemother"}],"container-title":["Biofilm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207526000274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207526000274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:15:05Z","timestamp":1783124105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590207526000274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"alternative-id":["S2590207526000274"],"URL":"https:\/\/doi.org\/10.1016\/j.bioflm.2026.100370","relation":{},"ISSN":["2590-2075"],"issn-type":[{"value":"2590-2075","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence of cefiderocol-persistence in Pseudomonas aeruginosa in vitro biofilms and in a murine infection model","name":"articletitle","label":"Article Title"},{"value":"Biofilm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioflm.2026.100370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100370"}}